News Archive

APOSEC attenuates secondary damage following spinal cord injury (31 Mar. 2015)

Thomas Haider et al. The secretome of apoptotic human peripheral blood mononuclear cells attenuates secondary damage following spinal cord injury in rats. PDF Download --> See also: Key Publications

go back to news archive

Latest News
Dec
12

Approval for clinical phase II study in DFU by Austrian health agency

[more]

Oct
10

US Patent Office issues Allowance for APOSEC Patent

[more]